Synaptic remodeling in the arcuate nucleus during the estrous cycle is induced by estrogen and precedes the preovulatory gonadotropin surge.
We have shown that the ovarian cycle is accompanied by a fall in the axosomatic synapses on randomly selected neurons of the arcuate nucleus by the morning of estrus, with a return to the preovulatory levels by the morning of metestrus, indicating a possible role in positive feedback. However, it remains to be proven that the circulating estradiol is the actual regulator of this physiological synaptic plasticity, or that estrogen-induced synaptic retraction precedes in the surge of gonadotropins at midcycle. To resolve these questions, we used an estradiol-immunoneutralization protocol and studied arcuate nucleus axosomatic synapses during the critical points of the estrous cycle. In addition to blocking positive feedback, estrogen immunoneutralization abolished synaptic retraction in the arcuate nucleus. As a positive control, the nonbinding estrogen diethylstilbestrol maintained the gonadotropin surge and synaptic retraction in the antiestradiol-treated animals. Furthermore, in the diluent-treated cycling control females, the synaptic retraction was found to precede the preovulatory LH surge. We demonstrated that the midcycle synaptic retraction of arcuate nucleus synapses is induced by the preovulatory estradiol surge, and that these morphological events precede the preovulatory gonadotropin surge. Taken together, these observations strongly suggest that the hypothalamic mechanism underlying the physiological disinhibition of gonadotropins at midcycle (positive feedback) requires estrogen-induced synaptic retraction in the arcuate nucleus.
Naftolin
F
F
Department of Obstetrics & Gynecology & Center for Research in Reproductive Biology, Yale University, New Haven, Connecticut 06510-8063, USA.
Mor
G
G
Horvath
T L
TL
Luquin
S
S
Fajer
A B
AB
Kohen
F
F
Garcia-Segura
L M
LM
D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000494:pharmacology; D001111:Arcuate Nucleus of Hypothalamus / Q000187:drug effects / Q000502:physiology*; D010064:Embryo Implantation / Q000187:drug effects; D004958:Estradiol / Q000276:immunology / Q000494:pharmacology*; D004971:Estrus / Q000502:physiology*; D005260:Female; D005498:Follicular Phase; D007986:Luteinizing Hormone / Q000378:metabolism*; D009473:Neuronal Plasticity; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D013569:Synapses / Q000187:drug effects / Q000502:physiology*
D000906:Antibodies; D004958:Estradiol; D007986:Luteinizing Hormone